TREATCANAVAN.COM: Keyword Density Checker

Total words: 1048 | 2-word phrases: 276 | 3-word phrases: 301 | 4-word phrases: 311

PAGE INFO

Title	Try to keep the title under 60 characters (52 characters) Canavan Disease Clinical Trial \| ASPA Clinical Trial
Description	Try to keep the meta description between 50 - 160 characters (247 characters) Aspa Therapeutics is developing an investigational gene therapy to treat patients with Canavan disease. CANaspire – a clinical trial designed to study the safety and potential effectiveness of an investigational gene therapy in Canavan patients.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	new candidate form	5	1.66%
2	an investigational gene	4	1.33%
3	investigational gene therapy	3	1.00%
4	for canavan disease	3	1.00%
5	natural history study	2	0.66%
6	with canavan disease	2	0.66%
7	patients with canavan	2	0.66%
8	treat patients with	2	0.66%
9	terms of use	2	0.66%
10	2023 aspa inc	2	0.66%
11	all rights reserved	2	0.66%
12	aspa inc all	2	0.66%
13	inc all rights	2	0.66%
14	© 2023 aspa	2	0.66%
15	a child’s brain	1	0.33%
16	acid naa if	1	0.33%
17	– that breaks	1	0.33%
18	that breaks down	1	0.33%
19	brain and may	1	0.33%
20	breaks down a	1	0.33%
21	down a chemical	1	0.33%
22	a chemical compound	1	0.33%
23	chemical compound called	1	0.33%
24	nacetyllaspartic acid naa	1	0.33%
25	naa if naa	1	0.33%
26	in a child’s	1	0.33%
27	if naa is	1	0.33%
28	naa is not	1	0.33%
29	and may prevent	1	0.33%
30	is not broken	1	0.33%

#	Keyword	Frequency	Density
1	an investigational gene therapy	3	0.96%
2	treat patients with canavan	2	0.64%
3	patients with canavan disease	2	0.64%
4	inc all rights reserved	2	0.64%
5	aspa inc all rights	2	0.64%
6	2023 aspa inc all	2	0.64%
7	© 2023 aspa inc	2	0.64%
8	a rare neurodegenerative disorder	1	0.32%
9	to working with canavan	1	0.32%
10	committed to working with	1	0.32%
11	firmly committed to working	1	0.32%
12	is firmly committed to	1	0.32%
13	aspa is firmly committed	1	0.32%
14	cure for canavan disease	1	0.32%
15	in developing therapies for	1	0.32%
16	experience in developing therapies	1	0.32%
17	leadership team with extensive	1	0.32%
18	extensive experience in developing	1	0.32%
19	with extensive experience in	1	0.32%
20	team with extensive experience	1	0.32%
21	with canavan patient advocacy	1	0.32%
22	canavan disease is a	1	0.32%
23	disease is a rare	1	0.32%
24	is a rare neurodegenerative	1	0.32%
25	rare neurodegenerative disorder caused	1	0.32%
26	neurodegenerative disorder caused by	1	0.32%
27	disease and assembled a	1	0.32%
28	working with canavan patient	1	0.32%
29	groups and families affected	1	0.32%
30	up to stay connected	1	0.32%
31	to study the safety	1	0.32%
32	potential approval of the	1	0.32%
33	canavan disease throughout the	1	0.32%
34	by canavan disease throughout	1	0.32%
35	canaspire – a clinical	1	0.32%
36	– a clinical trial	1	0.32%
37	a clinical trial designed	1	0.32%
38	clinical trial designed to	1	0.32%
39	trial designed to study	1	0.32%
40	designed to study the	1	0.32%